Muni prioritise safety in communities
The meeting's purpose was to generate ideas on how to strengthen working relationships among the stakeholders within the Community Safety Forum.
Ward Councillors, the South African Local Government Association, Cooperative Governance, Human Settlements and Traditional Affairs, Nkangala District Municipality, Community Development Workers, the Department of Community Safety and Liaison, the Department of Social Development, the Department of Justice, the SAPS, the Community Policing Forum, Mpumalanga Economic Regulator, the Department of Health and Department of Education, as well as Amakhosi and Traditional Healers were represented.
Alcohol was the most contributing factor in relation to crime.
Law enforcement agencies will now focus on the easy access to alcohol and drugs within the community at large.
Alcohol is also the number one contributor to gender-based violence.
Home affairs was also encouraged to scrutinise the nationality of the homeless people found on the streets.
Attendees agreed that a database of the homeless needed to be created.
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
TOMI Environmental Solutions Announces Major New Customer Win for 2025
FREDERICK, Md., Aug. 12, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ('TOMI') (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it has received significant purchase orders from a globally recognized leader in eye health. The company had placed an order for multiple Surface Units and disinfection carts for its South Carolina facility earlier in the year. In the third quarter of 2025, a second order was placed for the Florida facility. Notably, the South Carolina validation package was successfully completed, demonstrating repeatable, high-quality surface treatment results. As seen in recent years, the FDA has emphasized the importance of complete decontamination of hard to clean equipment with technologies which can penetrate the smallest cracks and crevices. SteraMist successfully passed repeatable trials against Geobacillus stearothermophilus spores, a challenging industry benchmark for manual surface spraying, further demonstrating the competitive advantage and reliability of its iHP technology. The Florida facility is planned to undergo qualification in the near term using the same methodology as the prior facility. The Company expects that the total amount of purchases from this customer will be approximately $385,000 for 2025, comprising of SteraMist iHP equipment, BIT Solution, and support services. This engagement underscores strong customer validation and growing demand for TOMI's validated disinfection solutions across multiple facilities. "We are incredibly proud to expand our partnership with this leader in global eye health," said Jim Reynolds, TOMI Manufacturing Sales Representative, President of ProEx Services. "This repeat business is a powerful testament to the performance and reliability of our iHP disinfection systems and the value they bring to customers operating in the most demanding regulatory environments. We are committed to quality and safety at their facilities and expanding our partnership to include their other locations.' TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments. For additional information, please visit or contact us at info@ Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, the expected purchase amount from customer and statements relating to TOMI's products to serve healthcare sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. INVESTOR RELATIONS CONTACT:John Nesbett/Rosalyn ChristianIMS Investor Relationstomi@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
William Blair Remains Bullish on Genmab A/S (GMAB)
Genmab A/S (NASDAQ:GMAB) is one of the top most undervalued biotech stocks to buy now. On August 7, William Blair analyst Matt Phipps reiterated a bullish stance on Genmab A/S (NASDAQ:GMAB), giving the stock a Buy rating without assigning a price target. A scientist in a lab using a microscope to develop new treatments for Multiple Myeloma. The analyst supported the rating with the company's solid financial performance and promising pipeline developments, stating that Genmab A/S (NASDAQ:GMAB) surpassed both consensus and internal revenue estimates, reporting strong fiscal Q2 results. He attributed the growth to a notable sales growth of Epkinly and robust royalties from Darzalex and Kesimpta. The company's financial strength prompted an upward revision of the full-year revenue guidance, suggesting increased confidence in solid performance by Genmab A/S (NASDAQ:GMAB), the analyst added. Genmab A/S (NASDAQ:GMAB) is an international biotechnology company that develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes DARZALEX to treat certain indications of multiple myeloma, TEPEZZA for the treatment of thyroid eye disease, and Arzerra to treat certain indications of chronic lymphocytic leukemia. While we acknowledge the potential of GMAB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
11 minutes ago
- Yahoo
ABCS Insights Ranks No. 59 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies While Achieving No. 3 National Ranking Among Advertising, Marketing, and Public Relations Companies
KISSIMMEE, Fla., Aug. 12, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that ABCS Insights is No. 59 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, and Under Armour. The top 500 will be listed in the Fall issue of Inc. magazine. Founded in 2020, ABCS Insights has quickly emerged as a disruptive force in the media measurement space. The company provides full-funnel campaign validation and optimization—including brand lift, consideration lift, and sales lift—by linking ad exposure to business outcomes using privacy-safe (PII-free and cookieless), deterministic datasets. Its measurement platform draws on a unified panel that includes: A 23 million-household receipt panel A 20 million-member U.S. survey panel A 70 million-user location data panel Through a test-versus-control methodology and precise audience segmentation, ABCS empowers clients to improve ROI across channels and stages of the customer journey. The firm's rapid growth has been fueled by high demand for independent, transparent, and verifiable advertising performance data—especially as marketers increasingly seek to justify media spend across retail media networks, connected TV, out-of-home, and other digital ecosystems. "This recognition is a testament to the value our team delivers to media publishers, advertising agencies, and brands seeking real-world, measurable outcomes from their campaigns," said Jerome Shimizu, CEO of ABCS Insights. "We're honored to be among the top 100 fastest-growing companies in the country and proud to represent the future of advertising measurement." Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years. "As brands demand higher accountability from their media partners, our focus on outcomes over proxies has resonated deeply with the market," Shimizu added. "We see this recognition not just as a milestone, but as momentum to keep innovating." For the full list, company profiles, and a searchable database by industry and location, visit: "Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision," says Mike Hofman, editor-in-chief of Inc. "These businesses have thrived amid rising costs, shifting global dynamics, and constant change." Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. About ABCS InsightsFounded in 2020 and headquartered in Kissimmee, Florida, ABCS Insights is a leading provider of outcome-based advertising measurement. With a mission of "Making Media More Valuable," the company empowers media publishers, advertising and media agencies, and intermediaries such as SSPs and DSPs to quantify the real-world impact of advertising. Using a privacy-first, cookieless, and PII-free methodology, ABCS links media exposure to business outcomes through deterministic, test-versus-control models and scalable, survey-based approaches. ABCS also provides advanced audience segmentation and in-flight optimization capabilities, powered by a unified dataset covering over 40 million U.S. more about ABCS Insights visit About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit Media Contact: Ned BuffonABCS Insights(760) 364-6630399557@ View original content to download multimedia: SOURCE ABCS Insights
